Gliadel, XRT, Temodar, Avastin Followed by Avastin, Temodar for Newly Diagnosed Glioblastoma Multiforme (GBM)
Clinical trial NCT01186406 · TERMINATED
Trial details
- NCT number
- NCT01186406
- Sponsor
- Duke University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2014-06-16
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.